Granite Bay Wealth Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,449
| Closed | -$232K | – | 82 |
|
|
2024
Q1 | $232K | Sell |
2,449
-265,013
| -99% | -$25.1M | 0.13% | 72 |
|
|
2023
Q4 | $19.8M | Sell |
267,462
-2,500
| -0.9% | -$186K | 0.18% | 58 |
|
|
2023
Q3 | $21.6M | Buy |
269,962
+264,988
| +5,327% | +$21.2M | 0.21% | 50 |
|
|
2023
Q2 | $414K | Sell |
4,974
-3,978
| -44% | -$331K | 0.39% | 33 |
|
|
2023
Q1 | $682K | Hold |
8,952
| – | – | 0.48% | 34 |
|
|
2022
Q4 | $743K | Sell |
8,952
-850
| -9% | -$70.5K | 0.48% | 28 |
|
|
2022
Q3 | $777K | Buy |
9,802
+202
| +2% | +$16K | 0.62% | 23 |
|
|
2022
Q2 | $713K | Buy |
9,600
+400
| +4% | +$29.7K | 0.55% | 25 |
|
|
2022
Q1 | $827K | Buy |
9,200
+6,450
| +235% | +$580K | 0.67% | 24 |
|
|
2021
Q4 | $308K | Buy |
+2,750
| New | +$308K | 0.3% | 39 |
|